Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6490394 | Journal of Biotechnology | 2018 | 9 Pages |
Abstract
Fowl adenoviruses (FAdVs) are widely considered as excellent platforms for vaccine development and gene therapy. We improved on our right-end partial TR-2 deleted or a left-end 2.3â¯kb deleted vectors by developing a single, dual-site delivery vector. We demonstrated that, in addition to ORF11, the right end ORF17 is also dispensable. To further improve the capacity and flexibility of the FAdV-9 based vector system, we generated an infectious recombinant FAdV-9 dual-site expression clone lacking 1.9â¯kb of the left end and replaced with mCherry under the control of a native promoter, and 3.6â¯kb of the right-end replaced with an EGFP expression cassette. Five intermediate FAdmid clones were successfully constructed: a) pFAdV-9Î0-2RED (mCherry replacing the left end 2.2â¯kb ORF0 to 2); b) pFAdV-9RED (mCherry replacing the left end 1.9â¯kb ORF1 to 2); c) pFAdV-9Î17 (deletion of ORF17 and 393â¯bp downstream untranslated region); d) pFAdV-9GFP (EGFP expression cassette replacing the right end 3.6â¯kb) and e) pFAdV-9Dual (both mCherry in the left end and the EGFP expression cassette in the right end of our vector). Our novel FAdV-9 dual-site vaccine vector, produced infectious virus and expressed either one or both mCherry and EGFP.
Keywords
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Yanlong Pei, Peter J. Krell, Ãva Nagy,